Acorai, is developing an AI-based medical device that could become the first non-invasive monitor of blood pressure within the heart. The product combines special sensors with the patient’s mobile phone and is intended for use in the home environment by people who suffer from heart failure. It has the potential to sharply reduce the number of hospital readmissions for such patients.
Filip founded Acorai in 2019 with the vision of transforming the treatment and management of heart failure through novel technology and applied machine learning. He has several years of experience working with Artificial Intelligence within quantitative finance in London and Switzerland and has an MA in Economics from the University of Edinburgh.
Did you know?
50% of heart failure patients require readmission within 6 months, 75% of which may be preventable.